control |
N2 |
|
3.9 |
563 |
spontaneous steriles |
N2 |
|
0.0 |
334 |
heat shock: 34°C for 45 min, 4 hr recovery |
N2 |
|
2.4 |
430 |
adr-1(gv6); adr-2(gv42)
|
BB4 |
RNA editing; [70]
|
0.8 |
777 |
dcr-1(ok247)
|
BB1 |
Dicer; [71]
|
0.5 |
743 |
rde-1(ne300);ced-1(e1735);ced-3(n717)
|
JJ2230 |
defective in RNAi and cell death pathways; increases titer of viruses in infected cultured cells; [11], [12], [13], [14]
|
4.0 |
155 |
rde-1(ne300);ced-1(e1735);ced-3(n717) day 5 adults |
JJ2230 |
defective in RNAi and cell death pathways; increases titer of viruses in infected cultured cells; [11], [12], [13], [14]
|
0.6 |
997 |
ppw-1(pk2505)
|
NL2550 |
defective in germline RNAi; [72]
|
0.0 |
968 |
prg-1(n4357); prg-2(n4358)
|
MT14769 |
Piwi proteins; mutants defective in transposon silencing; [73], [74], |
0.0 |
356 |
kgb-1(um3);kgb-2(km16)
|
KB7 |
P granule regulation; [75]
|
0.2 |
553 |
alg-1(RNAi); alg-2(ok304)
|
WM53 |
microRNA pathway; [76]
|
8.0 |
510 |
MAGO12 |
WM191 |
mutations in each of 12 Argonaute proteins, RNAi defective; [77]
|
5.5 |
604 |
unc-119(ed3); arIs37; cdIs32[pcc1::DT-A(E148D); unc-119(+) pmyo2::GFP]
|
NP17 |
no coelomocytes; [78]
|
6.7 |
134 |
Cer1(RNAi)
|
N2 |
LTR retrotransposon; [8]
|
0.0 |
1213 |
Cer2(RNAi)
|
N2 |
LTR retrotransposon; [8]
|
5.9 |
669 |
Cer3(RNAi)
|
N2 |
LTR retrotransposon; [8]
|
5.5 |
599 |
Cer4(RNAi)
|
N2 |
LTR retrotransposon; [8]
|
3.8 |
739 |
Cer5(RNAi)
|
N2 |
LTR retrotransposon; [8]
|
6.3 |
642 |
Cer6(RNAi)
|
N2 |
LTR retrotransposon; [8]
|
5.1 |
622 |
Cer13(RNAi)
|
N2 |
LTR retrovirus; [8]
|
2.6 |
728 |